Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
17.16B
Market cap17.16B
Price-Earnings ratio
22.71
Price-Earnings ratio22.71
Dividend yield
1.10%
Dividend yield1.10%
Average volume
2.68M
Average volume2.68M
High today
$88.88
High today$88.88
Low today
$86.81
Low today$86.81
Open price
$87.58
Open price$87.58
Volume
521.26K
Volume521.26K
52 Week high
$108.29
52 Week high$108.29
52 Week low
$79.12
52 Week low$79.12

Stock Snapshot

With a market cap of 17.16B, Zimmer Biomet(ZBH) trades at $88.72. The stock has a price-to-earnings ratio of 22.71 and currently yields dividends of 1.10%.

On 2026-07-06, Zimmer Biomet(ZBH) stock traded between a low of $86.81 and a high of $88.88. Shares are currently priced at $88.72, which is +2.2% above the low and -0.2% below the high.

Zimmer Biomet(ZBH) shares are trading with a volume of 521.26K, against a daily average of 2.68M.

During the past year, Zimmer Biomet(ZBH) stock moved between $79.12 at its lowest and $108.29 at its peak.

During the past year, Zimmer Biomet(ZBH) stock moved between $79.12 at its lowest and $108.29 at its peak.

ZBH News

TipRanks 3h
Zimmer Biomet price target lowered to $110 from $120 at Evercore ISI

Evercore ISI lowered the firm’s price target on Zimmer Biomet (ZBH) to $110 from $120 and keeps an Outperform rating on the shares. The firm’s Q2 preview for Me...

Simply Wall St 4d
Zimmer Biomet Stock Looks Cheap On Earnings But Faces Growth Doubts

Zimmer Biomet Holdings has fallen about 40.9% over the past five years, yet on current checks the stock still screens as undervalued, which raises the question...

Zimmer Biomet Stock Looks Cheap On Earnings But Faces Growth Doubts
Nasdaq 6d
Pacira To Sell Iovera Business To Zimmer Biomet; Pacira Shares Up

(RTTNews) - Pacira BioSciences Inc. (PCRX) on Tuesday announced an agreement to divest its iovera business to Zimmer Biomet Holdings (ZBH) for up to $140 millio...

Pacira To Sell Iovera Business To Zimmer Biomet; Pacira Shares Up

Analyst ratings

68%

of 28 ratings
Buy
28.6%
Hold
67.9%
Sell
3.6%

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.